Results 271 to 280 of about 87,574 (284)
Some of the next articles are maybe not open access.

Intravenous versus subcutaneous immunoglobulin

The Lancet Neurology, 2018
Ravi, Uniyal   +4 more
openaire   +2 more sources

Subcutaneous anti-COVID-19 hyperimmune immunoglobulin

2023
Background Anti-COVID-19 hyperimmune immunoglobulin (hIG) can provide standardized and controlled antibody content. Data from controlled clinical trials using hIG for the prevention or treatment of COVID-19 outpatients have not been reported. We assessed the safety and efficacy of subcutaneous anti-COVID-19 hyperimmune immunoglobulin 20% (C19-IG20 ...
Alemany, A   +29 more
openaire   +1 more source

[Intravenous and subcutaneous immunoglobulin therapy].

Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2015
Patients with agammaglobulinaemia and hypogammaglobulinaemia require immunoglobulin G (IgG) replacement therapy to prevent serious infections. Since the 1950s, therapy with human immune globulin products has been the standard of treatment. Currently, the most common routes of administration of IgG replacement therapy are intravenous (IVIG) or ...
openaire   +1 more source

Subcutaneous Administration of Immunoglobulins

Clinical Immunotherapeutics, 1996
Ann Gardulf, Lennart Hammarström
openaire   +1 more source

Subcutaneous Immunoglobulin

Immunology and Allergy Clinics of North America, 2012
openaire   +1 more source

Rapid subcutaneous immunoglobulin infusions in children

The Lancet, 1993
M J, Thomas, V M, Brennan, H H, Chapel
openaire   +2 more sources

New choices for treatment with subcutaneous immunoglobulins

Medicina Clínica (English Edition), 2017
Daniel E, Pleguezuelo   +1 more
openaire   +2 more sources

Skin Necrosis Following Subcutaneous Immunoglobulin (SCIg)

Journal of Clinical Immunology, 2016
Emily Carne   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy